Fetal Cardiac Magnetic Resonance in Detection of CHD

Fetal Cardiac Magnetic Resonance Imaging Using DUS Gating on 3T: Preliminary Experiences in Detection of CHD

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05066399

Enrollment

100

Registered

2021-10-04

Start date

2021-05-11

Completion date

2023-09-30

Last updated

2021-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease, Fetal Cardiac Disorder, Heart Defect, Congenital

Brief summary

The aim of this clinical prospective study is to investigate the value of fetal cardiac magnetic resonance imaging using a new Doppler ultrasound based gating method for the detection of congenital heart desease.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* fetuses in third trimenon * congenital heart defect suspected by obstetric ultrasound

Exclusion criteria

* pregnant women with contraindication for native MRI

Design outcomes

Primary

Measure	Time frame	Description
The number of heart defect characteristics detectable by DUS gated Cine MRI imaging	Up to 3 months after birth, cardiac MRI findings will be compared against fetal ultrasound gainst fetal ultrasounand against findings after birth (reference standard).	DUS gated Cine imaging will be applied to detect characteristics of clinically suspected congenital heart defects.

Countries

Germany

Contacts

Primary ContactJulian A. Luetkens, PD Dr.

julian.luetkens@ukbonn.de+49 228 287-15960

Backup ContactThomas M. Vollbrecht, Dr.

thomas.vollbrecht@ukbonn.de+49 228 287-15960

Outcome results